WHAT WE WANT TO BE
Ewopharma is the innovative partner for the marketing of pharmaceuticals and consumer health products in Switzerland and Central Eastern Europe.
“We are ensuring our success as an independent, owner managed company by systematically expanding our specialty pharma and consumer health business. We are also strengthening our hospital business in the interest of diversification and increasing returns.”
Alain Staub, President of the Board of Directors and CEO.
Inosine Acedoben Dimepranol (IAD)
Inosine Acedoben Dimepranol (IAD) is the lead product of Newport Pharmaceuticals Ltd.
CORE ACTIVITIES
At Newport we are a Corporate Support Centre for the Ewopharma Group.
GATEWAY TO
EASTERN EUROPE
Newport's strategic operations In Ireland and access to the Central Eastern European Markets means we are looking for new niche pharmaceutical & Consumer Health business opportunities.
NEWPORT IN
IRELAND
Newport Pharmaceuticals Limited has been established in Dublin, Ireland for more than 30 years.
News & Media
Allergycare AG Becomes part of Ewopharma Group
Schaffhausen, 03/06/24 – Ewopharma AG, a privately held Swiss healthcare...
Read More
Ewopharma and CStone enter into a strategic partnership for sugemalimab in Central Eastern Europe and Switzerland
Schaffhausen, Švicarska, 27. maj 2024 – Ewopharma announces today that it...
Read More
Can-Fite expands the out-licensing deal with Ewopharma to include the pancreatic cancer indication
PETACH TIKVA, Israel, January 30, 2024 – Can-Fite BioPharma Ltd....
Read More